Manual Communication: Clinical Trials

9 trials for Manual Communication, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 active not recruiting, 3 completed, 1 enrolling by invitation, 1 suspended. 8 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable8Active not recruiting 3, Completed 3, Enrolling by invitation 1, Suspended 1

Follow Manual Communication: new trials by email Literature Review of Manual Communication trials Research Report on Manual Communication

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Single Case Research Design: Deaf Children's Language Outcomes
Strategic and Interactive Signing Instruction - Language Development
Not applicableActive not recruitingThe University of Tennessee, Knoxville82025-08-012025-11-24
Adaptation and Normalization of a Verbal Episodic Memory Test in French Sign Language
Questionnaire and Physical Exam - Neuropsychological Tests, Memory
Not applicableSuspendedPoitiers University Hospital1202025-05-052026-10-16
Strategic and Interactive Signing Instruction Experiment
Strategic and Interactive Signing Instruction, Business-As-Usual Instruction - Sign Language Skills, Teacher Practice
Not applicableActive not recruitingThe University of Tennessee, Knoxville1502025-04-012026-08-28
Strategic and Interactive Signing Instruction
Strategic and Interactive Signing Instruction - Teaching Behaviors, Sign Language Skills
Not applicableEnrolling by invitationThe University of Tennessee, Knoxville1502024-08-232024-10-31
Single Case Research Design: Teacher Outcomes
Strategic and Interactive Signing Instruction - Teacher Practice
Not applicableCompletedThe University of Tennessee, Knoxville42024-08-232025-12-19
Pre- and Post- Descriptive Data of Language Outcomes in Deaf Children
Business-as-usual instruction - Sign Language Skills
Active not recruitingThe University of Tennessee, Knoxville1602024-08-012025-01-20
On-site Supportive Communication Training in Doctor-patient Communication
On-site supportive communication training - Communication Programs, Communication, Manual
Not applicableCompletedVejle Hospital892023-05-012024-06-26
Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL
ASL Services - Deafness, Hearing Loss
Not applicableActive not recruitingUniversity of Connecticut402021-07-202025-07-11
Mini-Mental State (MMS-LS) and Sign Language
application of the mini-mental state test - Prelingual Deafness, Retention Disorders, Cognitive
Not applicableCompletedLille Catholic University1952011-06-172019-02-15

Narrower conditions

Sign Language (8)  ·  Deafness (3)  ·  Alzheimer Disease (1)  ·  Burnout, Psychological (1)  ·  Cognitive Dysfunction (1)  ·  Communication (1)  ·  Hearing Loss (1)  ·  Language (1)  ·  Memory Disorders (1)  ·  Neoplasms (1)  ·  Occupational Stress (1)  ·  Patient Satisfaction (1)

Broader conditions

Behavior (9)  ·  Nonverbal Communication (9)  ·  Communication (8)  ·  Language (7)  ·  Ear Diseases (3)  ·  Hearing Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Hearing Loss (2)  ·  Behavioral Symptoms (1)

Interventions

Restraint, Physical (1)  ·  Surveys and Questionnaires (1)

Sponsors

The University of Tennessee, Knoxville (5)  ·  Lille Catholic University (1)  ·  Poitiers University Hospital (1)  ·  University of Connecticut (1)  ·  Vejle Hospital (1)

Countries

United States (6)  ·  France (2)  ·  Denmark (1)

Top investigators

Leala Holcomb, PhD (2)  ·  Charlotte Crinquette, MD (1)  ·  Corine Gilda Scemama-Ammar, MD (1)  ·  Diane C Lillo-Martin, Ph.D. (1)  ·  Isabelle Bouillevaux, MD (1)  ·  Isabelle Ridoux, MD (1)  ·  Kerstin Kiis Antonsen, MD (1)

Results publications

PMID 38730382, PMID 39849449, PMID 40640105

NIH funding

R21DC021024 (5), R01DC016901 (1)